195 related articles for article (PubMed ID: 31586230)
1. Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis.
Bodensohn R; Hadi I; Fleischmann DF; Corradini S; Thon N; Rauch J; Belka C; Niyazi M
Strahlenther Onkol; 2020 Jan; 196(1):70-76. PubMed ID: 31586230
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.
Yonezawa S; Miwa K; Shinoda J; Nomura Y; Asano Y; Nakayama N; Ohe N; Yano H; Iwama T
J Neurooncol; 2014 Aug; 119(1):101-9. PubMed ID: 24789256
[TBL] [Abstract][Full Text] [Related]
3. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
[TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
[TBL] [Abstract][Full Text] [Related]
5. Single-shot bevacizumab for cerebral radiation injury.
Voss M; Wenger KJ; Fokas E; Forster MT; Steinbach JP; Ronellenfitsch MW
BMC Neurol; 2021 Feb; 21(1):77. PubMed ID: 33596839
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
Khan M; Zhao Z; Arooj S; Liao G
BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
[TBL] [Abstract][Full Text] [Related]
7. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
Liu AK; Macy ME; Foreman NK
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1148-54. PubMed ID: 19857784
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Relief of Cerebral Radiation Necrosis Treated with Low-Dose Bevacizumab - a Report of 2 Cases.
Hu Q; Zhao J; Xu J; Zhou X; Shui Y; Shen L; Wei Q
Oncol Res Treat; 2017; 40(3):133-137. PubMed ID: 28231593
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab for the Treatment of Gammaknife Radiosurgery-Induced Brain Radiation Necrosis.
Ma Y; Zheng C; Feng Y; Xu Q
J Craniofac Surg; 2017 Sep; 28(6):e569-e571. PubMed ID: 28749838
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.
Dahl NA; Liu AK; Foreman NK; Widener M; Fenton LZ; Macy ME
Childs Nerv Syst; 2019 Nov; 35(11):2043-2046. PubMed ID: 31367784
[TBL] [Abstract][Full Text] [Related]
13. The Safety and Efficacy of Bevacizumab for Radiosurgery - Induced Steroid - Resistant Brain Edema; Not the Last Part in the Ship of Theseus.
Tripathi M; Ahuja CK; Mukherjee KK; Kumar N; Dhandapani S; Dutta P; Kaur R; Rekhapalli R; Batish A; Gurnani J; Kamboj P; Agrahari A; Kataria K
Neurol India; 2019; 67(5):1292-1302. PubMed ID: 31744962
[TBL] [Abstract][Full Text] [Related]
14. Effect of bevacizumab on radiation necrosis of the brain.
Gonzalez J; Kumar AJ; Conrad CA; Levin VA
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):323-6. PubMed ID: 17236958
[TBL] [Abstract][Full Text] [Related]
15. High-dose bevacizumab for radiation-induced brain necrosis: a case report.
Panagiotou E; Charpidou A; Fyta E; Nikolaidou V; Stournara L; Syrigos A; Gkiozos I
CNS Oncol; 2023 Sep; 12(3):CNS98. PubMed ID: 37140173
[TBL] [Abstract][Full Text] [Related]
16. Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series.
Tijtgat J; Calliauw E; Dirven I; Vounckx M; Kamel R; Vanbinst AM; Everaert H; Seynaeve L; Van Den Berge D; Duerinck J; Neyns B
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174026
[TBL] [Abstract][Full Text] [Related]
17. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
[TBL] [Abstract][Full Text] [Related]
18. Indication of Bevacizumab for Cerebral Radiation Necrosis.
Zhuang H; Yuan X; Yuan Z; Wang P
Recent Pat Anticancer Drug Discov; 2017; 12(3):272-277. PubMed ID: 28443515
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab: radiation combination produces restricted diffusion on brain MRI.
Hesselink JR; Barkovich MJ; Seibert TM; Farid N; Muller KA; Murphy KT; Kesari S
CNS Oncol; 2014; 3(5):329-35. PubMed ID: 25363005
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.
Foster KA; Ares WJ; Pollack IF; Jakacki RI
Pediatr Blood Cancer; 2015 Feb; 62(2):240-245. PubMed ID: 25382690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
